Back to Results

Frelii Inc (FRLI)

Frelii, Inc. is a healthcare technology company focused on personalized, subscription-based nutrition and wellness programs. Through its frelii.com platform, the company provides health assessments and nutrition plans that incorporate genetic data, physiology, environmental and lifestyle factors, and laboratory diagnostics. Its offerings also include lab diagnostic kits, compounding pharmacy products, and nutritional and vitamin supplements. Formerly known as Vican Resources, Inc., the company adopted the Frelii, Inc. name in March 2018. Frelii is based in Lehi, Utah, and its common stock trades on OTC Markets under the symbol FRLI.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-FRLI
Not available
Not available
Not available
Weak
0.0%
0.058 K
Valuation • Fair Value

Frelii Inc (OTC-FRLI) Fair Value by Valuation Model

No usable valuation estimate is currently available for Frelii Inc (OTC-FRLI); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Frelii Inc (OTC-FRLI). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Frelii Inc (OTC-FRLI)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Frelii Inc (OTC-FRLI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Frelii Inc (OTC-FRLI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Frelii Inc (OTC-FRLI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Frelii Inc (OTC-FRLI)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Frelii Inc (OTC-FRLI). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Frelii Inc (OTC-FRLI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Frelii Inc (OTC-FRLI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Frelii Inc (OTC-FRLI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Frelii Inc (OTC-FRLI) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Frelii Inc (OTC-FRLI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Frelii Inc (OTC-FRLI) Stock FAQ

Data-supported answers about Frelii Inc (OTC-FRLI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Weak
Current financial-health read

A reliable fair value estimate is not currently available for Frelii Inc (OTC-FRLI). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Frelii Inc (OTC-FRLI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Frelii Inc (OTC-FRLI).

The current market capitalization listed for Frelii Inc is 0.058 K.

The ticker symbol for Frelii Inc is OTC-FRLI, and the stock is listed on OTC Markets.

Frelii Inc (OTC-FRLI) is listed on OTC Markets.

Similar Health Care Technology Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

VEEV NYSE Veeva Systems Inc Class A Fair Value Fair Market Cap 42.13 B
WAY NASDAQ Waystar Holding Corp Fair Value Undervalued Market Cap 4.92 B
DOCS NYSE Doximity Inc Fair Value Undervalued Market Cap 4.654 B
HTFL NASDAQ Heartflow Inc Fair Value Overvalued Market Cap 4.413 B
SDGR NASDAQ Schrodinger Inc Fair Value Overvalued Market Cap 2.171 B
CERT NASDAQ Certara Inc Fair Value Undervalued Market Cap 1.284 B
GDRX NASDAQ Goodrx Holdings Inc Fair Value Undervalued Market Cap 1.153 B
TDOC NYSE Teladoc Inc Fair Value Undervalued Market Cap 1.145 B
HSTM NASDAQ HealthStream Inc Fair Value Fair Market Cap 893.1 M
SOPH NASDAQ Sophia Genetics SA Fair Value Overvalued Market Cap 698.9 M
PHR NYSE Phreesia Inc Fair Value Undervalued Market Cap 623.2 M
CTEV NYSE Claritev Corp Fair Value Fair Market Cap 522.2 M
EVH NYSE Evolent Health Inc Fair Value Undervalued Market Cap 417.2 M
SLP NASDAQ Simulations Plus Inc Fair Value Undervalued Market Cap 372.9 M
AMWL NYSE American Well Corp Fair Value Fair Market Cap 233.9 M
LFMD NASDAQ LifeMD Inc Fair Value Undervalued Market Cap 155.4 M
DH NASDAQ Definitive Healthcare Corp Fair Value Bargain Market Cap 138.8 M
OPRX NASDAQ OPTIMIZERx Corp Fair Value Bargain Market Cap 136.7 M
HCAT NASDAQ Health Catalyst Inc Fair Value Fair Market Cap 134 M
CCLD NASDAQ CareCloud Inc Fair Value Fair Market Cap 91.787 M